BNP Paribas Financial Markets’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.2M Buy
909,306
+94,125
+12% +$1.58M 0.01% 884
2025
Q1
$12.5M Sell
815,181
-522,289
-39% -$8.03M 0.01% 916
2024
Q4
$29.5M Buy
1,337,470
+168,699
+14% +$3.72M 0.02% 622
2024
Q3
$21.1M Sell
1,168,771
-548,003
-32% -$9.88M 0.01% 580
2024
Q2
$27.9M Sell
1,716,774
-355,732
-17% -$5.78M 0.02% 472
2024
Q1
$29.2M Buy
2,072,506
+645,353
+45% +$9.11M 0.03% 452
2023
Q4
$14.9M Buy
1,427,153
+266,579
+23% +$2.78M 0.02% 570
2023
Q3
$11.8M Sell
1,160,574
-189,435
-14% -$1.93M 0.02% 564
2023
Q2
$10.2M Buy
1,350,009
+62,640
+5% +$472K 0.01% 651
2023
Q1
$11.4M Sell
1,287,369
-19,352
-1% -$171K 0.02% 604
2022
Q4
$11.9M Buy
1,306,721
+663
+0.1% +$6.05K 0.02% 607
2022
Q3
$10.5M Buy
1,306,058
+179,402
+16% +$1.45M 0.02% 663
2022
Q2
$8.47M Buy
1,126,656
+170,694
+18% +$1.28M 0.01% 692
2022
Q1
$8.98M Sell
955,962
-645,538
-40% -$6.06M 0.01% 714
2021
Q4
$12.8M Buy
1,601,500
+103,518
+7% +$829K 0.02% 580
2021
Q3
$14.6M Sell
1,497,982
-584,008
-28% -$5.69M 0.02% 503
2021
Q2
$20.6M Buy
2,081,990
+476,148
+30% +$4.71M 0.03% 444
2021
Q1
$18.5M Sell
1,605,842
-220,048
-12% -$2.54M 0.03% 405
2020
Q4
$17.6M Buy
1,825,890
+494,654
+37% +$4.77M 0.03% 350
2020
Q3
$12M Buy
1,331,236
+210,058
+19% +$1.89M 0.02% 496
2020
Q2
$13.8M Buy
1,121,178
+238,343
+27% +$2.94M 0.02% 407
2020
Q1
$7.93M Sell
882,835
-166,414
-16% -$1.49M 0.02% 539
2019
Q4
$10.3M Sell
1,049,249
-933,819
-47% -$9.15M 0.02% 532
2019
Q3
$13.6M Buy
1,983,068
+161,100
+9% +$1.11M 0.02% 417
2019
Q2
$16.8M Buy
1,821,968
+375,580
+26% +$3.47M 0.03% 316
2019
Q1
$22.7M Buy
1,446,388
+27,240
+2% +$427K 0.05% 239
2018
Q4
$21.9M Sell
1,419,148
-345,228
-20% -$5.32M 0.05% 216
2018
Q3
$38M Sell
1,764,376
-103,334
-6% -$2.23M 0.06% 215
2018
Q2
$45.4M Sell
1,867,710
-179,557
-9% -$4.37M 0.08% 162
2018
Q1
$35M Sell
2,047,267
-37,702
-2% -$644K 0.07% 186
2017
Q4
$39.5M Buy
2,084,969
+381,739
+22% +$7.23M 0.07% 111
2017
Q3
$30M Buy
1,703,230
+661,710
+64% +$11.6M 0.07% 221
2017
Q2
$34.6M Sell
1,041,520
-706,840
-40% -$23.5M 0.1% 181
2017
Q1
$56.1M Buy
1,748,360
+237,310
+16% +$7.62M 0.15% 134
2016
Q4
$54.8M Buy
1,511,050
+1,202,533
+390% +$43.6M 0.26% 71
2016
Q3
$14.2M Buy
308,517
+88,350
+40% +$4.06M 0.06% 228
2016
Q2
$11.1M Buy
220,167
+71,292
+48% +$3.58M 0.05% 265
2016
Q1
$7.97M Sell
148,875
-205,305
-58% -$11M 0.03% 426
2015
Q4
$23.2M Buy
354,180
+278,344
+367% +$18.3M 0.06% 267
2015
Q3
$4.28M Sell
75,836
-96,813
-56% -$5.47M 0.01% 683
2015
Q2
$10.2M Sell
172,649
-17,016
-9% -$1.01M 0.03% 359
2015
Q1
$11.8M Buy
189,665
+89,959
+90% +$5.6M 0.03% 360
2014
Q4
$5.73M Sell
99,706
-830,297
-89% -$47.8M 0.02% 607
2014
Q3
$50M Buy
930,003
+819,091
+739% +$44M 0.04% 177
2014
Q2
$5.81M Sell
110,912
-32,850
-23% -$1.72M 0.01% 554
2014
Q1
$7.02M Sell
143,762
-38,199
-21% -$1.87M 0.01% 539
2013
Q4
$12.5M Sell
181,961
-60,168
-25% -$4.13M 0.01% 391
2013
Q3
$9.15M Buy
242,129
+26,044
+12% +$984K 0.01% 504
2013
Q2
$8.47M Buy
+216,085
New +$8.47M 0.01% 342